Literature DB >> 23963898

Immunohistochemical distribution of cell cycle proteins p27, p57, cyclin D3, PCNA and Ki67 in normal and diabetic human placentas.

Gozde Unek1, Aslı Ozmen, Inanc Mendilcioglu, Mehmet Simsek, Emin Turkay Korgun.   

Abstract

The placenta is a regulator organ for many metabolic activities between mother and fetus. Therefore, fetal growth is directly related to the placental development. Placental development is a series of events that depend on the coordinated action of trophoblasts' proliferation, differentiation and invasion. Studies on cell cycle related proteins which control these events are fairly limited. How placental tissue proliferation is affected by diabetes is not exactly known yet. Therefore in this study, the immunohistochemical localizations of cell cycle related proteins like PCNA, Ki67, cyclin D3, p27 and p57 in the differentiation, proliferation and apoptosis mechanisms of normal and diabetic placentas were investigated. Information on cell cycle related proteins that control these events is limited and how they are affected in diabetes mellitus is not fully understood yet. Therefore, in this study, to understand the role of cell cycle regulators in diabetic placentas we aimed to determine the spatio-temporal immunolocalizations of cell cycle regulators in diabetic and normal human term placentas. Term placentas were obtained from diabetic women and from normal pregnancies with informed consent following caesarean deliveries. Placental samples were stained via immunohistochemistry with PCNA, Ki67, cyclin D3, p27 and p57 antibodies and were examined by light microscopy. When compared to control placentas, PCNA, Ki67 and cyclin D3 staining intensities significantly increased in villous parts of diabetes group. Moreover, Ki67 and cyclin D3 stainings also significantly increased in basal plates and chorionic plate respectively. In chorionic plates, p27 and p57 staining intensities significantly decreased in diabetic group. p57 staining also significantly decreased in villous parts of diabetic placentas. Placental abnormalities seen in diabetic placentas could be associated with proliferation and cell cycle arrest mechanisms' alterations occurred in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963898     DOI: 10.1007/s10735-013-9534-3

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  52 in total

1.  Intrauterine growth retardation in experimental diabetes: possible role of the placenta.

Authors:  R Padmanabhan; M Shafiullah
Journal:  Arch Physiol Biochem       Date:  2001-07       Impact factor: 4.076

2.  Oxygen modulates the response of first-trimester trophoblasts to hyperglycemia.

Authors:  Julia D Fröhlich; Berthold Huppertz; Peter M Abuja; Julia König; Gernot Desoye
Journal:  Am J Pathol       Date:  2011-11-03       Impact factor: 4.307

3.  Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose.

Authors:  C Kühl
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

4.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

Review 5.  Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation.

Authors:  D S Charnock-Jones; P Kaufmann; T M Mayhew
Journal:  Placenta       Date:  2004 Feb-Mar       Impact factor: 3.481

6.  Fibrinoid necrosis and hyalinization observed in normal, diabetic and hypertensive placentae.

Authors:  Farrah Shams; Muhammad Rafique; Nawaz Ali Samoo; Raheel Irfan
Journal:  J Coll Physicians Surg Pak       Date:  2012-12       Impact factor: 0.711

7.  MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels.

Authors:  Ursula Hiden; Elisabeth Glitzner; Marina Ivanisevic; Josip Djelmis; Christian Wadsack; Uwe Lang; Gernot Desoye
Journal:  Diabetes       Date:  2007-10-10       Impact factor: 9.461

8.  The effect of systemic corticosteroid treatment on the immunolocalisation of Notch-1, Delta, CD105 and CD166 in rat articular cartilage.

Authors:  Ozlem Ozbey; Zeliha Sahin; A Merter Ozenci; Nuray Acar; Ismail Ustunel
Journal:  Acta Histochem       Date:  2009-05-30       Impact factor: 2.479

9.  Is there a relationship between PCNA expression and diabetic placental development during pregnancy?

Authors:  Nuray Acar; Emin Turkay Korgun; Sevil Cayli; Zeliha Sahin; Ramazan Demir; Ismail Ustunel
Journal:  Acta Histochem       Date:  2008-04-02       Impact factor: 2.479

10.  Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors.

Authors:  D Jaskulski; C Gatti; S Travali; B Calabretta; R Baserga
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

View more
  11 in total

1.  Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.

Authors:  Ting Zhu; Zhengxiang Ji; Caixia Xu; Zhiyang Peng; Liang Gu; Rui Zhang; Yangchen Liu
Journal:  J Mol Histol       Date:  2014-07-16       Impact factor: 2.611

Review 2.  Effects of maternal diabetes on trophoblast cells.

Authors:  Marlúcia Bastos Aires; Anne Carolline Veríssimo Dos Santos
Journal:  World J Diabetes       Date:  2015-03-15

3.  Decreased expression and activation of Stat3 in severe preeclampsia.

Authors:  Zhan Zhang; Xiaoqian Yang; Linlin Zhang; Zhenfeng Duan; Liting Jia; Peng Wang; Ying Shi; Ying Li; Junjun Gao
Journal:  J Mol Histol       Date:  2015-03-10       Impact factor: 2.611

4.  Ultrastructure alteration of decidual natural killer cells in women with unexplained recurrent miscarriage: a possible association with impaired decidual vascular remodelling.

Authors:  Shaima M Almasry; Rasha A Elmansy; Amr K Elfayomy; Samy A Algaidi
Journal:  J Mol Histol       Date:  2014-10-30       Impact factor: 2.611

5.  Gestational protein restriction alters cell proliferation in rat placenta.

Authors:  Hércules Jonas Rebelato; Marcelo Augusto Marreto Esquisatto; Eloá Fernanda de Sousa Righi; Rosana Catisti
Journal:  J Mol Histol       Date:  2016-01-16       Impact factor: 2.611

6.  Heat shock protein-27 (HSP27) regulates STAT3 and eIF4G levels in first trimester human placenta.

Authors:  Gali Epstein Shochet; Oded Komemi; Dana Sadeh-Mestechkin; Meir Pomeranz; Ami Fishman; Liat Drucker; Michael Lishner; Shelly Tartakover Matalon
Journal:  J Mol Histol       Date:  2016-10-06       Impact factor: 2.611

7.  Placental Homing Peptide-microRNA Inhibitor Conjugates for Targeted Enhancement of Intrinsic Placental Growth Signaling.

Authors:  Frances Beards; Lisa E Jones; Jayne Charnock; Karen Forbes; Lynda K Harris
Journal:  Theranostics       Date:  2017-07-14       Impact factor: 11.556

8.  The interplay of BDNF-TrkB with NMDA receptor in propofol-induced cognition dysfunction : Mechanism for the effects of propofol on cognitive function.

Authors:  Junfei Zhou; Fang Wang; Jun Zhang; Jianfeng Li; Li Ma; Tieli Dong; Zhigang Zhuang
Journal:  BMC Anesthesiol       Date:  2018-04-05       Impact factor: 2.217

9.  Type 1 Diabetes Mellitus and the First Trimester Placenta: Hyperglycemia-Induced Effects on Trophoblast Proliferation, Cell Cycle Regulators, and Invasion.

Authors:  Alejandro Majali-Martinez; Ursula Weiss-Fuchs; Heidi Miedl; Desiree Forstner; Julia Bandres-Meriz; Denise Hoch; Josip Djelmis; Marina Ivanisevic; Ursula Hiden; Martin Gauster; Gernot Desoye
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

10.  The role, mechanism and potentially novel biomarker of microRNA-17-92 cluster in macrosomia.

Authors:  Jing Li; Liping Chen; Wei Wu; Yankai Xia; Daozhen Chen; Yali Hu; Xinru Wang
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.